Overview
- 66 inspections across 57 sites are on record.
- 54 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2011-08-19.
At a glance
Inspections
66
Sites
57
Observations
54
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Dr. Reddy'S Laboratories | 19 Aug 2011 | ||
| Bristol Myers Squibb | 27 Jul 2011 | View 483 → | |
| Johnson & Johnson Pharmaceutical Research & Development, LLC | 30 Jun 2011 | ||
| Rasi Laboratories, Inc. | 21 Jun 2011 | View 483 → | |
| Sanofi-Aventis U.S. LLC | 3 Jun 2011 |
Sites inspected
Dr. Reddy'S LaboratoriesBridgewater, United States1 insp.
Bristol Myers SquibbPrinceton, United States1 insp.
Johnson & Johnson Pharmaceutical Research & Development, LLCRaritan, United States1 insp.
Rasi Laboratories, Inc.Cranbury, United States1 insp.
Sanofi-Aventis U.S. LLCBridgewater, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Denise M Visco6 shared
Sarah M Forney4 shared
Dorothy J Denes4 shared
Michael R Klapal2 shared
Addam S Reynolds2 shared
Nicholas A Violand2 shared
Byungja E Marciante2 shared
Maria Estrella1 shared
Deborah B Nixon1 shared
Doreen P Gubbay1 shared
Full investigator report
Get the verbatim findings behind Dawn L Wydner's 54 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site